[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

DK361983A - PROCEDURE FOR PREPARING MELDROD ALCOALOIDS - Google Patents

PROCEDURE FOR PREPARING MELDROD ALCOALOIDS Download PDF

Info

Publication number
DK361983A
DK361983A DK361983A DK361983A DK361983A DK 361983 A DK361983 A DK 361983A DK 361983 A DK361983 A DK 361983A DK 361983 A DK361983 A DK 361983A DK 361983 A DK361983 A DK 361983A
Authority
DK
Denmark
Prior art keywords
meldrod
alcoaloids
preparing
procedure
preparing meldrod
Prior art date
Application number
DK361983A
Other languages
Danish (da)
Other versions
DK361983D0 (en
Inventor
Peter Gull
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of DK361983D0 publication Critical patent/DK361983D0/en
Publication of DK361983A publication Critical patent/DK361983A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D457/00Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/02Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/18Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/24Antidepressants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/26Psychostimulants, e.g. nicotine, cocaine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
DK361983A 1982-08-09 1983-08-08 PROCEDURE FOR PREPARING MELDROD ALCOALOIDS DK361983A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH4772/82A CH649998A5 (en) 1982-08-09 1982-08-09 ERGOL DERIVATIVES, A METHOD FOR THEIR PRODUCTION AND HEALING AGENTS, CONTAINING THESE ERGOL DERIVATIVES AS AN ACTIVE SUBSTANCE.

Publications (2)

Publication Number Publication Date
DK361983D0 DK361983D0 (en) 1983-08-08
DK361983A true DK361983A (en) 1984-02-10

Family

ID=4282273

Family Applications (1)

Application Number Title Priority Date Filing Date
DK361983A DK361983A (en) 1982-08-09 1983-08-08 PROCEDURE FOR PREPARING MELDROD ALCOALOIDS

Country Status (23)

Country Link
JP (1) JPS5948480A (en)
AT (1) AT383125B (en)
AU (1) AU563736B2 (en)
BE (1) BE897473A (en)
CA (1) CA1215972A (en)
CH (1) CH649998A5 (en)
DE (1) DE3327705A1 (en)
DK (1) DK361983A (en)
ES (1) ES8502992A1 (en)
FI (1) FI73679C (en)
FR (1) FR2531433B1 (en)
GB (1) GB2125041B (en)
GR (1) GR78923B (en)
HU (1) HU187600B (en)
IL (1) IL69450A (en)
IT (1) IT1168961B (en)
MY (1) MY8700166A (en)
NL (1) NL8302776A (en)
NZ (1) NZ205181A (en)
PH (1) PH20385A (en)
PT (1) PT77168B (en)
SE (1) SE8304315L (en)
ZA (1) ZA835850B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675322A (en) * 1984-12-10 1987-06-23 Eli Lilly And Company 1-Substituted-6-n-propyl-8β-methylthio-methylergolines
HU193782B (en) * 1985-06-21 1987-11-30 Richter Gedeon Vegyeszet Process for producing 2-halogeno-nicergoline derivatives and acid additional salts thereof
FR2589734B1 (en) * 1985-11-13 1988-09-02 Roussel Uclaf USE OF ERGOLIN DERIVATIVES FOR OBTAINING A GERIATRIC MEDICINE
US4798834A (en) * 1987-08-31 1989-01-17 Eli Lilly And Company Optionally substituted (3β-9,10-didehydro-2,3-dihydro ergoline as serotonergic function enhancement
DE3913756A1 (en) * 1989-04-21 1990-10-25 Schering Ag 8 (BETA) SUBSTITUTED ERGOLINE, METHOD FOR THE PRODUCTION AND USE THEREOF
DE10212564B4 (en) * 2002-03-12 2007-04-19 Neurobiotec Gmbh 1-Allyl ergot alkaloid derivatives and their use for the prophylaxis and treatment of migraine

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE41533B1 (en) * 1974-03-14 1980-01-30 Sandoz Ltd Thiomethyl ergolene derivatives
US3901894A (en) * 1974-06-06 1975-08-26 Lilly Co Eli 8-thiomethylergolines
US3959288A (en) * 1974-12-13 1976-05-25 Eli Lilly And Company 8-Oxymethylergolines and process therefor
US4166182A (en) * 1978-02-08 1979-08-28 Eli Lilly And Company 6-n-propyl-8-methoxymethyl or methylmercaptomethylergolines and related compounds
US4382940A (en) * 1979-12-06 1983-05-10 Farmitalia Carlo Erba S.P.A. Ercoline derivatives and therapeutic compositions having CNS affecting activity

Also Published As

Publication number Publication date
IL69450A (en) 1986-10-31
SE8304315L (en) 1984-02-10
FI832789A (en) 1984-02-10
FI73679C (en) 1987-11-09
FR2531433B1 (en) 1985-10-18
BE897473A (en) 1984-02-06
ES524815A0 (en) 1985-02-01
AU1767283A (en) 1984-02-16
ZA835850B (en) 1985-03-27
ATA286383A (en) 1986-10-15
ES8502992A1 (en) 1985-02-01
GB8321222D0 (en) 1983-09-07
FI832789A0 (en) 1983-08-02
GB2125041A (en) 1984-02-29
FI73679B (en) 1987-07-31
DE3327705A1 (en) 1984-02-09
CA1215972A (en) 1986-12-30
CH649998A5 (en) 1985-06-28
GB2125041B (en) 1986-04-23
AU563736B2 (en) 1987-07-23
SE8304315D0 (en) 1983-08-08
FR2531433A1 (en) 1984-02-10
DK361983D0 (en) 1983-08-08
NZ205181A (en) 1986-07-11
NL8302776A (en) 1984-03-01
MY8700166A (en) 1987-12-31
PT77168B (en) 1986-03-27
IT1168961B (en) 1987-05-20
AT383125B (en) 1987-05-25
HU187600B (en) 1986-01-28
PH20385A (en) 1986-12-08
IT8322490A0 (en) 1983-08-09
GR78923B (en) 1984-10-02
JPS5948480A (en) 1984-03-19
PT77168A (en) 1983-09-01
IL69450A0 (en) 1983-11-30

Similar Documents

Publication Publication Date Title
DK350083D0 (en) PROCEDURE FOR PREPARING PHENYLETHANOLAMINES
DK470583A (en) PROCEDURE FOR PREPARING 1-PHENYL-2-PIPERIDINOPROPANOL DERIVATIVES
DK162057C (en) PROCEDURE FOR PREPARING AN IMMUNOGENT COMPLEX
DK156283D0 (en) PROCEDURE FOR PREPARING Grease-Glycoside Mixtures
DK606084A (en) PROCEDURE FOR PREPARING 2-FLUOR-17BETA EESTRADIOL
DK386784D0 (en) PROCEDURE FOR PREPARING ALFA-6-DESOXY-TETRACYCLINES
DK299483D0 (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK153583D0 (en) PROCEDURE FOR PREPARING SUBSTITUTED PENEME DERIVATIVES
DK211783D0 (en) PROCEDURE FOR PREPARING PYRAZOLPYRIDE COMPOUNDS
DK283083A (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK451883D0 (en) PROCEDURE FOR PREPARING 4-METHYL-5-ALKYLTHIOMETHYL-IMIDAZOLES
DK71783A (en) PROCEDURE FOR PREPARING PYRIMIDON DERIVATIVES
DK37890D0 (en) PROCEDURE FOR PREPARING 6-DEOXYANTHRACYCLINES
DK394783D0 (en) PROCEDURE FOR PREPARING N-PHOSPHONOMETHYLGYLINE
DK361983A (en) PROCEDURE FOR PREPARING MELDROD ALCOALOIDS
DK399783D0 (en) PROCEDURE FOR PREPARING SUBSTITUTED 1-PURIDYLOXY-3-INDOLYLALKYLAMINO-2-PROPANOLS
DK385983D0 (en) PROCEDURE FOR PREPARING 1-OXACEPHAMER
DK411881A (en) PROCEDURE FOR PREPARING 1-OXA-BETA-LACTAMANTIBIOTICS
DK380981A (en) PROCEDURE FOR PREPARING BENZOQUINOLIZINES
DK9383D0 (en) PROCEDURE FOR PREPARING PHOSPHINOXIDES
DK193983D0 (en) PROCEDURE FOR PREPARING SUBSTITUTED PHENYLENDIAMINES
DK573184A (en) PROCEDURE FOR PREPARING POLYPHENYLENOXIDE
DK137583D0 (en) PROCEDURE FOR PREPARING 2-PYRIDYALKYLAMINES
DK526983D0 (en) PROCEDURE FOR PREPARING SULPHONED O-PHENYLENDIAMINES
DK534281A (en) PROCEDURE FOR PREPARING 1-SULFO-2-OXOZETIME INGREDIATES